(Q46536104)

English

Pre-treatment haemoglobin level predicts response and survival after TPF induction polychemotherapy in advanced head and neck cancer patients

scientific article published in June 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559031

Pre-treatment haemoglobin level predicts response and survival after TPF induction polychemotherapy in advanced head and neck cancer patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559031

advanced head and neck cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

head and neck carcinoma

1 reference

based on heuristic

inferred from title

author name string

M Baghi

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559031

J Wagenblast

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559031

M Hambek

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559031

S Moertel

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559031

W Gstoettner

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559031

K Strebhardt

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559031

R Knecht

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559031

publication date

1 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559031

Clinical Otolaryngology

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559031

33

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559031

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559031

245-251

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559031

Current clinical outcomes demand new treatment options for SCCHN.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2008.01702.X

21 January 2018

Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2008.01702.X

21 January 2018

Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2008.01702.X

21 January 2018

Impact of haemoglobin levels on the outcome of cancers treated with chemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2008.01702.X

21 January 2018

Treatment of head and neck cancer: the role of chemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2008.01702.X

21 January 2018

Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2008.01702.X

21 January 2018

Erythropoietin increases hemoglobin during radiation therapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2008.01702.X

21 January 2018

Anaemia in cancer: pathophysiology and treatment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2008.01702.X

21 January 2018

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2008.01702.X

21 January 2018

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2008.01702.X

21 January 2018

Anemia is associated with lower local-regional control and survival after radiation therapy for head and neck cancer: a prospective study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2008.01702.X

21 January 2018

Anemia and elevated systemic levels of vascular endothelial growth factor (VEGF).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-4486.2008.01702.X

21 January 2018

Identifiers

10.1111/J.1749-4486.2008.01702.X

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559031

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18559031

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46536104&oldid=2116912376"